Synthesis of N‐Acetyl‐D‐ and ‐L‐Leucine‐13C6 Tool Compounds in Neurodegenerative Disease

Damien Crepin, Andrew McGown, Dawn Shepherd, Rebecca Braine, Manvendra Sharma, Jordan Nafie, João Gabriel Ribeiro, G Dan Pantoş, Grant Churchill, Frances M Platt, John Spencer · 2026

Read Synthesis of N‐Acetyl‐D‐ and ‐L‐Leucine‐13C6 Tool Compounds in Neurodegenerative Disease by Damien Crepin, Andrew McGown, Dawn Shepherd, Rebecca Braine, Manvendra Sharma, Jordan Nafie, João Gabriel Ribeiro, G Dan Pantoş, Grant Churchill, Frances M Platt, John Spencer (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13179125.txt.

Description

Damien Crepin and ten co-authors made labeled versions in 2026 of a drug used for a rare child brain disease. The drug is one mirror form of a modified amino acid; its twin form serves as a control. To trace the drug in the body and tell it apart from the body's own supply, the team needed versions built with a heavy form of carbon.

They built both mirror forms with six heavy carbons, plus a lighter tagged form, by a simple chemical step from the raw amino acids. Tests confirmed the products' identity, purity of form, and shelf stability. Such tracers let doctors follow exactly where the drug goes.

Catalog record

CREATORDamien Crepin, Andrew McGown, Dawn Shepherd, Rebecca Braine, Manvendra Sharma, Jordan Nafie, João Gabriel Ribeiro, G Dan Pantoş, Grant Churchill, Frances M Platt, John Spencer
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE19 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13179125

Browse the full library · About the Tower of Babel